TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24177257

Group type: EXPERIMENTAL
Intervention: 3 months of dual antiplatelet therapy (aspirin 100-200 mg daily and clopidogrel 75 mg daily)
Number of subjects: 3119

Group type: COMPARATOR
Intervention: 12 months of dual antiplatelet therapy (aspirin 100-200 mg daily and clopidogrel 75 mg daily)
Number of subjects: 3119
Study: 21867445

Group type: EXPERIMENTAL
Intervention: 10 mg rosuvastatin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 19417125

Group type: EXPERIMENTAL
Intervention: Pioglitazone (45 mg/day)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 17355726

Group type: EXPERIMENTAL
Intervention: Brief, friendly social connection with an experimenter
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral interaction with an experimenter
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional mood induction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Writing about a family member, friend, or favourite celebrity
Number of subjects: 0
Study: 15067427

Group type: EXPERIMENTAL
Intervention: Automatic bolus tracking
Number of subjects: 98

Group type: COMPARATOR
Intervention: Fixed time-delay examination (30 s delay)
Number of subjects: 98
Study: 11287528

Group type: EXPERIMENTAL
Intervention: Ash split catheter
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Opti-flow catheter
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Tesio catheter
Number of subjects: 94

Group type: COMPARATOR
Intervention: Comparison of all catheters
Number of subjects: 94
Study: 9787863

Group type: EXPERIMENTAL
Intervention: Remifentanil combined with desflurane (0.5 MAC = 3.0 vol%)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Remifentanil combined with propofol (6 mg/kg/h)
Number of subjects: 40
Study: 8087442

Group type: EXPERIMENTAL
Intervention: Breast-conserving therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Total mastectomy
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 2502799

Group type: EXPERIMENTAL
Intervention: Intravenous m-chlorophenylpiperazine (0.1 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral m-chlorophenylpiperazine (0.5 mg/kg)
Number of subjects: 0
Study: 782699

Group type: EXPERIMENTAL
Intervention: Methyl‐CCNU and 5‐fluorouracil (5‐FU) combination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methyl‐CCNU
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methyl‐CCNU and cyclophosphamide combination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CCNU
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Streptozotocin
Number of subjects: 0
Study: 31944791

Group type: EXPERIMENTAL
Intervention: OCPD
Number of subjects: 107

Group type: COMPARATOR
Intervention: AvPD
Number of subjects: 107
Study: 31264766

Group type: EXPERIMENTAL
Intervention: Novel TAAR shampoo
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 29054024

Group type: EXPERIMENTAL
Intervention: Social skills plus relaxation training (SSRT)
Number of subjects: 1
Study: 26051568

Group type: EXPERIMENTAL
Intervention: Acupressure at acupoints Neiquan (P6) and Zusanli (ST36) for 3 consecutive days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group receiving regular postoperative care
Number of subjects: 60
Study: 23283356

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4 µg/kg)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1.0 µg/kg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 21107246

Group type: EXPERIMENTAL
Intervention: FD‐ASOCT (RTVue‐100) for measuring tear meniscus height, depth, and cross-sectional area; corneal fluorescein staining; tear film breakup time; Schirmer I test; dry eye questionnaire.
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: FD‐ASOCT (RTVue‐100)
Number of subjects: 306
Study: 19211707

Group type: EXPERIMENTAL
Intervention: Exercise-only (EXO; 12 weeks of exercise without diet-restriction)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Hypocaloric-diet (DIO; 8 weeks of very low energy diet (VLED 600 kcal/day) followed by 4-weeks weight maintenance diet)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Hypocaloric-diet and exercise (DEX; 8 weeks VLED 800 kcal/day + 4-week weight maintenance diet combined with exercise throughout the 12 weeks)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 79
Study: 16713525

Group type: EXPERIMENTAL
Intervention: Advice from a general practitioner (GP)
Number of subjects: 3622

Group type: EXPERIMENTAL
Intervention: Referral to a clinic
Number of subjects: 3622

Group type: EXPERIMENTAL
Intervention: Nicotine replacement
Number of subjects: 3622

Group type: EXPERIMENTAL
Intervention: Complementary treatments (acupuncture and hypnotherapy)
Number of subjects: 3622

Group type: EXPERIMENTAL
Intervention: Advice from family and friends
Number of subjects: 3622

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 3622
Study: 14718699

Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg daily for 12 months
Number of subjects: 692

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 692
Study: 12584861

Group type: EXPERIMENTAL
Intervention: Domestic bambuteral tablet
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Imported bambuteral tablet
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Domestic terbutaline
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Imported terbutaline
Number of subjects: 20
Study: 9222948

Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 1749

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1749
Study: 7926148

Group type: EXPERIMENTAL
Intervention: FSH alone (urofollitropin) after pituitary desensitization using buserelin acetate nasal spray
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: IVF‐ET
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: GIFT
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: Cumulative rates for either treatment
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: Women > 40 years old
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: Sperm disorder cases in women < 40 years old
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: Sperm disorder cases in women > 40 years old
Number of subjects: 773
Study: 3281308

Group type: EXPERIMENTAL
Intervention: Group 1: '00' Dexon subcutaneous and '00' prolene subcuticular sutures
Number of subjects: 50

Group type: COMPARATOR
Intervention: Group 2: single layer of interrupted '00' nylon sutures
Number of subjects: 50
Study: 31175709

Group type: EXPERIMENTAL
Intervention: Odanacatib (300 mg on day 1, then daily multiple doses of 25 mg to day 21)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Moxifloxacin (single 400 mg dose on day 4)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 28399219

Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention targeting identified risk factors including physiotherapy, occupational therapy, geriatric assessment, optometry, and medication management
Number of subjects: 221

Group type: COMPARATOR
Intervention: Individualised written fall prevention advice (Control)
Number of subjects: 221
Study: 25861621

Group type: EXPERIMENTAL
Intervention: Cinacalcet
Number of subjects: 44
Study: 23327199

Group type: EXPERIMENTAL
Intervention: Thymosin alpha 1 (Tα1)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 361
Study: 21382511

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 129

Group type: COMPARATOR
Intervention: USDA's MyPyramid diet for Pregnancy and Breastfeeding (control diet)
Number of subjects: 129
Study: 18435777

Group type: EXPERIMENTAL
Intervention: Diabetes Manual 1:1 structured education
Number of subjects: 245

Group type: COMPARATOR
Intervention: Control group (6-month delayed-intervention)
Number of subjects: 245
Study: 16420539

Group type: EXPERIMENTAL
Intervention: High-resolution ultrasound reflex transmission imaging (RTI)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: White light (WL) digital photography
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of quantitative parameters from RTI and WL photography
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: RTI and WL imaging combined
Number of subjects: 24
Study: 12766756

Group type: EXPERIMENTAL
Intervention: Adrenolutin measured at baseline and at 1 month
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Adrenolutin levels at 1 month
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Baseline adrenolutin levels
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Adrenolutin levels 1 month after random assignment
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Left ventricular ejection fraction
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: New York Heart Association class
Number of subjects: 263
Study: 11049912

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 9059951

Group type: EXPERIMENTAL
Intervention: Nadolol (80 mg p.o. acute; chronic therapy for 2 months)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Nadolol (80 mg p.o. chronic therapy for 2 months)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 8368985

Group type: EXPERIMENTAL
Intervention: Benadryl (diphenhydramine), 50 mg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Hismanal (astemizole), 10 mg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 3126122

Group type: EXPERIMENTAL
Intervention: Growth-hormone releasing hormone (GHRH)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Thyrotropin-releasing hormone (TRH)
Number of subjects: 15
Study: 30016450

Group type: EXPERIMENTAL
Intervention: Enhanced family/peer support (n=72)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Enhanced nutrition education (n=73)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Standard care (n=73)
Number of subjects: 218
Study: 27834411

Group type: EXPERIMENTAL
Intervention: Pretreatment with oxalic acid followed by the application of a two‐step etch‐and‐rinse adhesive system
Number of subjects: 20

Group type: COMPARATOR
Intervention: Two‐step etch‐and‐rinse adhesive technique (control)
Number of subjects: 20
Study: 25556881

Group type: EXPERIMENTAL
Intervention: Polysorb(®) short-term absorbable sutures
Number of subjects: 55

Group type: COMPARATOR
Intervention: PDS(®)II long-term absorbable sutures
Number of subjects: 55
Study: 23949898

Group type: EXPERIMENTAL
Intervention: Saxagliptin 5 mg once daily
Number of subjects: 455

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 455
Study: 21666445

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 18582395

Group type: EXPERIMENTAL
Intervention: Pentosan polysulfate sodium (PPS) 300 mg/day
Number of subjects: 128
Study: 16649882

Group type: EXPERIMENTAL
Intervention: Panic Control Therapy (PCT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 80
Study: 14528786

Group type: EXPERIMENTAL
Intervention: Intervention group from nine CME programs (Perinatology, Pain Management, Fertility Care 2, Pediatrics, Colorectal Diseases, Alzheimer's Disease)
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: Combined intervention group from nine CME programs
Number of subjects: 667

Group type: COMPARATOR
Intervention: Control group from nine CME programs
Number of subjects: 667
Study: 10780139

Group type: EXPERIMENTAL
Intervention: Peer with organic disease
Number of subjects: 363

Group type: COMPARATOR
Intervention: Peer without organic disease
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Same sex peer
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Peer with stress
Number of subjects: 363

Group type: COMPARATOR
Intervention: Peer without stress
Number of subjects: 363
Study: 8622596

Group type: EXPERIMENTAL
Intervention: Diet 12:0 + 14:0
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Diet 16:0 + 18:0
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Diet 14:0 + 16:0
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: All experimental diets
Number of subjects: 18
Study: 1315645

Group type: EXPERIMENTAL
Intervention: Synthetic human atrial natriuretic factor (3 pmol min‐1 kg‐1) co-infused with arginine vasopressin
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Arginine vasopressin infusion (0.1 m‐units min‐1 kg‐1)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo co-infused with arginine vasopressin
Number of subjects: 9
Study: 29426574

Group type: COMPARATOR
Intervention: Orthosis alone
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Combination of orthosis, nerve/tendon gliding exercises, and ultrasound therapy
Number of subjects: 41
Study: 30002307

Group type: EXPERIMENTAL
Intervention: Positive Photo Appreciation (PPA) program
Number of subjects: 55

Group type: COMPARATOR
Intervention: Photo Correspondence Education (PCE)
Number of subjects: 55
Study: 26381392

Group type: EXPERIMENTAL
Intervention: Individualized abutments
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard abutments
Number of subjects: 20
Study: 25115166

Group type: EXPERIMENTAL
Intervention: Intensive motivational interviewing (IMI)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Single standard session of motivational interviewing (SMI) combined with eight nutrition education sessions
Number of subjects: 217
Study: 22466469

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab (0.5 mg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab plus photodynamic therapy (PDT)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone (4 mg) plus PDT
Number of subjects: 37
Study: 21256402

Group type: EXPERIMENTAL
Intervention: Sensodyne® Pronamel® mouthrinse (450 ppm fluoride)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Colgate® Fluorigard® (225 ppm fluoride)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Listerine® Total Care (100 ppm fluoride)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Listerine Softmint Sensation (0 ppm fluoride)
Number of subjects: 16
Study: 17852431

Group type: EXPERIMENTAL
Intervention: Open cholecystectomy (group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy (group B)
Number of subjects: 40
Study: 16100449

Group type: EXPERIMENTAL
Intervention: Newfactan
Number of subjects: 492

Group type: COMPARATOR
Intervention: Surfacten
Number of subjects: 492
Study: 12103383

Group type: EXPERIMENTAL
Intervention: Intracardiac microaxial pump (ICP)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Normothermic cardiopulmonary bypass (CPB)
Number of subjects: 199
Study: 10411426

Group type: EXPERIMENTAL
Intervention: Cimetidine therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8983763

Group type: EXPERIMENTAL
Intervention: Cordaphene (30 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diltiazeme (180 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium antagonists (CAs)
Number of subjects: 0
Study: 2153475

Group type: EXPERIMENTAL
Intervention: Epinephrine 10 ng/kg/min
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Epinephrine 30 ng/kg/min
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Calcium chloride (10 mg/kg bolus followed by 2 mg/kg/hr infusion)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Epinephrine with Calcium
Number of subjects: 12
Study: 7225741

Group type: EXPERIMENTAL
Intervention: Chemotherapy (CMF)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Radiotherapy followed by chemotherapy
Number of subjects: 52
Study: 30076173

Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamicin 3 mg/m2 on days 1, 4, and 7 during induction and 3 mg/m2/day on day 1 during consolidation
Number of subjects: 271

Group type: COMPARATOR
Intervention: Conventional front-line induction chemotherapy (3+7 daunorubicin+cytarabine)
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamicin
Number of subjects: 271

Group type: COMPARATOR
Intervention: Control arm (no gemtuzumab ozogamicin)
Number of subjects: 271
Study: 28628374

Group type: EXPERIMENTAL
Intervention: Multispecies probiotic supplement (GeriLact; n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (n = 25)
Number of subjects: 50
Study: 26402448

Group type: EXPERIMENTAL
Intervention: DA-9701
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 23421963

Group type: EXPERIMENTAL
Intervention: Lurasidone 80 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lurasidone 40 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lurasidone 120 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lurasidone (all doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lurasidone
Number of subjects: 0
Study: 21351532

Group type: EXPERIMENTAL
Intervention: 32P application device (AD)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Microwave therapy
Number of subjects: 107
Study: 19761700

Group type: EXPERIMENTAL
Intervention: levamisole plus levocetirizine
Number of subjects: 132

Group type: COMPARATOR
Intervention: levocetirizine alone (control group)
Number of subjects: 132
Study: 17174639

Group type: EXPERIMENTAL
Intervention: Aspirin (50 mg) and dipyridamole (400 mg)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Aspirin (50 mg) and dipyridamole / Placebo
Number of subjects: 149
Study: 16356804

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day (intensive lipid lowering)
Number of subjects: 502

Group type: COMPARATOR
Intervention: Pravastatin 40 mg/day (moderate lipid lowering)
Number of subjects: 502
Study: 12105162

Group type: EXPERIMENTAL
Intervention: 300 mg allopurinol daily for 1 month
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 10337432

Group type: EXPERIMENTAL
Intervention: Emedastine 0.05% ophthalmic solution
Number of subjects: 36

Group type: COMPARATOR
Intervention: Ketorolac 0.5% ophthalmic solution
Number of subjects: 36
Study: 2108712

Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Tinidazole
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 390811

Group type: EXPERIMENTAL
Intervention: BCG adjuvant immunotherapy
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (no BCG treatment)
Number of subjects: 92
Study: 30968431

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (post‐tetanic count 1‐2) with high doses of rocuronium and 4 mg/kg of sugammadex
Number of subjects: 102

Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade (train‐of‐four 1‐2) with moderate doses of rocuronium and 2 mg/kg of sugammadex
Number of subjects: 102

Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade (train‐of‐four 1‐2)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (post‐tetanic count 1‐2)
Number of subjects: 102
Study: 29023563

Group type: EXPERIMENTAL
Intervention: Venex regeneration wear
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo product
Number of subjects: 13
Study: 25575334

Group type: EXPERIMENTAL
Intervention: Work-related self-affirming implementation intention (WS-AII)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control
Number of subjects: 66
Study: 23736997

Group type: EXPERIMENTAL
Intervention: Tamoxifen (1-3 years)
Number of subjects: 535

Group type: COMPARATOR
Intervention: No adjuvant therapy (Control)
Number of subjects: 535
Study: 21368682

Group type: EXPERIMENTAL
Intervention: HAF condition (randomized to receive HAF)
Number of subjects: 6939

Group type: COMPARATOR
Intervention: No HAF condition (randomized to not receive HAF)
Number of subjects: 6939
Study: 19002087

Group type: EXPERIMENTAL
Intervention: Recombinant human activated protein C (rh‐APC)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Tight glycemic control (TGC)
Number of subjects: 90
Study: 16765961

Group type: EXPERIMENTAL
Intervention: Percutaneous technique
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (traditional approach)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 13
Study: 14609312

Group type: EXPERIMENTAL
Intervention: Nutritional supplement (5 g of glycine, glutamine, and niacin, twice daily for 3 weeks)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (twice daily for 3 weeks)
Number of subjects: 42
Study: 11098502

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with mitomycin and 5‐FU followed by oral UFT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery alone (control)
Number of subjects: 0
Study: 8725605

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Minilaparotomy-cholecystectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 1423566

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 0
Study: 3974116

Group type: EXPERIMENTAL
Intervention: Thermodilution cardiac output measurements at peak-inspiration
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Thermodilution cardiac output measurements at end-exhalation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Thermodilution cardiac output measurements at random times in the respiratory cycle
Number of subjects: 32
Study: 30661022

Group type: EXPERIMENTAL
Intervention: Nurse-led advance care planning session (1.5 hours)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 165
Study: 28836456

Group type: EXPERIMENTAL
Intervention: EQ-5Dindex score at 3 months follow-up
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: EQ-5Dindex score at 12 months follow-up
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: External responsiveness analysis using PRWE-Swe
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Classification accuracy of EQ-5Dindex change scores
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Correlation analysis with Spearman's ρ test
Number of subjects: 132